Granpool Innovative Investments and Environmental Technologies Fund backed the round, which will support global expansion and technology development.
"The microbiome is a megatrend that is evolving very quickly, and we are the forefront of associated discovery with our unique solution to address the enterprise data challenge. We have our sights set too on other complex data challenges including CRISPR and quantum biological challenges, such as understanding the immune response more fully. The potential is phenomenal, and we are immensely grateful to our supporters for sharing our vision and helping us to scale at this pivotal time."
The Series C round was led by Draper Esprit with participation from ADV to help the digital healthcare provider scale its NHS services.
"At Push Doctor, we are in a privileged position to be able to provide a service that can make life easier for both GPs and patients. We want to continue and deepen the support we’ve already been providing throughout the pandemic, to help the NHS and patients emerge even stronger from Covid-19."
The debt facility was led by Avellinia Capital with backing from Clerville Investment Management.
"We believe the days of one-trip ownership are coming to an end. Under Raylo’s circular model, devices will be used by a minimum of two people over a lifespan of six to seven years."
London Stock Exchange Group and other major backers join Series B round to support international growth and technology development.
"The COVID-19 pandemic demonstrated the effectiveness of the public markets, with companies recapitalising quickly and efficiently. Our technology has allowed thousands of retail investors to participate on equal terms with institutional investors, unlocking a large and important source of liquidity and long-term share ownership for corporate issuers. The response from Boards and their advisers to our solution has been excellent: they recognise our digital solution for retail inclusion brings together both good governance and best execution."
